Market Place
Sourcing Support
Ocean Biomedical Receives Notice From Nasdaq For Late Filing
22 Nov 2024 //
GLOBENEWSWIRE
Ocean Biomedical Receives Nasdaq Staff Determination Letter
22 Oct 2024 //
GLOBENEWSWIRE
Ocean Biomedical pens $32M pact for Polish YKL-40 inhibitors
15 Oct 2024 //
FIERCE BIOTECH
Molecure & Ocean Bio Sign Licensing Agreement For YKL-40 Inhibitors
15 Oct 2024 //
GLOBENEWSWIRE
Ocean Biomedical Publishes Data on Novel Cancer Immunotherapy
01 Oct 2024 //
GLOBENEWSWIRE
Ocean Biomedical Announces Patent For PfGARP Malaria Antibodies
27 Aug 2024 //
GLOBENEWSWIRE
Ocean Biomedical Receives Nasdaq Notice For Late Quarterly Report Filing
23 Aug 2024 //
GLOBENEWSWIRE
Ocean Biomedical Announces Nasdaq Notice On Late 10-Q Filing
30 May 2024 //
GLOBENEWSWIRE
Ocean Biomedical Allowed Patent For Malaria Antibodies
16 May 2024 //
GLOBENEWSWIRE
Ocean Biomedical Receives Nasdaq Notice for Late 10-K Filing
24 Apr 2024 //
GLOBENEWSWIRE
Ocean Congratulates Virion, on Promising First-Ever Human Ph 1B Safety Data
28 Mar 2024 //
GLOBENEWSWIRE
Ocean Announces Joint Venture Partner, Virion to Present Data as Presentation
29 Feb 2024 //
GLOBENEWSWIRE
Ocean Biomedical Announces Publication of Groundbreaking Breast Cancer Research
05 Dec 2023 //
GLOBENEWSWIRE
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq
29 Nov 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Positive Preclinical Oncology Data for VRON-0300
14 Nov 2023 //
GLOBENEWSWIRE
Ocean Announces First Patients Dosed by Virion in Ph 1b of Novel Immunotherapy
26 Oct 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces $1 Million Falk Award for Malaria Drug Candidate
24 Oct 2023 //
GLOBENEWSWIRE
Ocean Bio Announces Enrollment of Patients for Phase 1b for Chronic Hepatitis B
17 Oct 2023 //
GLOBENEWSWIRE
Ocean Biomedical and Virion Therapeutics Form Joint Venture
12 Oct 2023 //
GLOBENEWSWIRE
Ocean Bio Announces Loan Commitment from Largest Stockholder; Up to $10 Million
04 Oct 2023 //
GLOBENEWSWIRE
Ocean Biomedical AnnouncesAgreement with Polar Multi-Strategy Master Fund
04 Oct 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Agreement with a Key Financing Partner
03 Oct 2023 //
GLOBENEWSWIRE
Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria
14 Sep 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces New Patent for Anti-Fibrosis Discovery with Allowance
29 Aug 2023 //
GLOBENEWSWIRE
Ocean Biomedical Provides Latest Updates on its Broad Programs in Malaria
10 Aug 2023 //
GLOBENEWSWIRE
Ocean Biomedical Celebrates 95% Lung Cancer Tumor Reduction Results
01 Aug 2023 //
GLOBENEWSWIRE
Ocean Bio Vaccine Candidate Generates Over 90% Killing of Malaria Parasites
11 Jul 2023 //
GLOBENEWSWIRE
Ocean Biomedical, Inc. Joins the Russell 2000® Index
27 Jun 2023 //
GLOBENEWSWIRE
Ocean Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment
26 Jun 2023 //
GLOBENEWSWIRE
Ocean Biomedical Extends Patent Rights for Breakthrough IPF
23 Jun 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Share Price Target Increase to $17.63 by Research
21 Jun 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Malaria Vaccine Patent Granted in Brazil
08 Jun 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Initiation of Coverage by Taglich Brothers
01 Jun 2023 //
GLOBENEWSWIRE
Ocean Biomedical (NASDAQ: OCEA) Announces Addition to the Russell 2000® Index
25 May 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Patent Award for Novel Cancer Immunotherapy Treatment
23 May 2023 //
GLOBENEWSWIRE
Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility
16 May 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces 70% Increase in Price Target by EF Hutton
01 May 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces New Glioblastoma Results Tumor Suppression
27 Apr 2023 //
GLOBENEWSWIRE
Ocean Biomedical on World Malaria Day Announces Sharing of New Malaria Vaccine
25 Apr 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Notice of Allowance for U.S. Patent
20 Apr 2023 //
GLOBENEWSWIRE
$134M in Financial Backing for Research and IND Fillings Announced by Ocean Bio
17 Apr 2023 //
GLOBENEWSWIRE
Ocean Bio Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory
21 Mar 2023 //
GLOBENEWSWIRE
Ocean Announces Initiation of Equity Analyst Coverage by Fundamental Research
16 Mar 2023 //
GLOBENEWSWIRE
Ocean Biomedical Announces Initiation of Equity Analyst Coverage
14 Mar 2023 //
GLOBENEWSWIRE
Ocean Biomedical Shares Detailed Research Data on Anti-Tumor Pathway Discoveries
09 Mar 2023 //
GLOBENEWSWIRE
Ocean Biomedical to Ring The Nasdaq Stock Market Opening Bell
16 Feb 2023 //
GLOBENEWSWIRE
Ocean Debuts as Traded Company Focused on Commercialization of Innovative Assets
15 Feb 2023 //
GLOBENEWSWIRE
Ocean and Aesther Announce the Award of New Patents for Antibodies
09 Feb 2023 //
GLOBENEWSWIRE
Aesther & Ocean Biomedical Announce Shareholder Approval of Business Combination
06 Feb 2023 //
GLOBENEWSWIRE
Ocean and Aesther Announce Publication of Data in Malignant Melanoma
30 Jan 2023 //
GLOBENEWSWIRE
Ocean Biomedical Provides Corporate Update and Company Summary
24 Jan 2023 //
GLOBENEWSWIRE
Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting
01 Nov 2022 //
GLOBENEWSWIRE
Aesther Healthcare Acquisition Corp Announces Filing of Preliminary Proxy
19 Sep 2022 //
GLOBENEWSWIRE
Discovery of Bispecific Antibodies & Immune Checkpoint Glioblastoma Cells
06 Sep 2022 //
GLOBENEWSWIRE
